Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Robert A Blake

Showing results (21-30 of 31) with videos related to

Pageof 4
Sort By:
Cell|July 30, 2019
Therapeutic Ligands Antagonize Estrogen Receptor Function by Impairing Its MobilityJane Guan, Wei Zhou, Marc Hafner, et al.
Bioorganic & Medicinal Chemistry Letters|August 23, 2021
Discovery of GNE-502 as an orally bioavailable and potent degrader for estrogen receptor positive breast cancerJason R Zbieg, Jun Liang, Jun Li, et al.
Chemistry (Weinheim an Der Bergstrasse, Germany)|March 2, 2018
Conjugation of Indoles to Antibodies through a Novel Self-Immolating LinkerPeter S Dragovich, Robert A Blake, Chunjiao Chen, et al.
Chemmedchem|November 2, 2019
Antibody Conjugation of a Chimeric BET Degrader Enables in vivo ActivityThomas H Pillow, Pragya Adhikari, Robert A Blake, et al.
Journal of Medicinal Chemistry|February 17, 2021
Antibody-Mediated Delivery of Chimeric BRD4 Degraders. Part 1: Exploration of Antibody Linker, Payload Loading, and Payload Molecular PropertiesPeter S Dragovich, Thomas H Pillow, Robert A Blake, et al.
Journal of Medicinal Chemistry|February 17, 2021
Antibody-Mediated Delivery of Chimeric BRD4 Degraders. Part 2: Improvement of In Vitro Antiproliferation Activity and In Vivo Antitumor EfficacyPeter S Dragovich, Thomas H Pillow, Robert A Blake, et al.
Bioorganic & Medicinal Chemistry Letters|January 7, 2020
Antibody-mediated delivery of chimeric protein degraders which target estrogen receptor alpha (ERα)Peter S Dragovich, Pragya Adhikari, Robert A Blake, et al.
Nature|October 19, 2017
USP7 small-molecule inhibitors interfere with ubiquitin bindingLorna Kategaya, Paola Di Lello, Lionel Rougé, et al.
Elife|July 14, 2016
The selective estrogen receptor downregulator GDC-0810 is efficacious in diverse models of ER+ breast cancerJames D Joseph, Beatrice Darimont, Wei Zhou, et al.
Elife|January 8, 2019
Correction: The selective estrogen receptor downregulator GDC-0810 is efficacious in diverse models of ER+ breast cancerJames D Joseph, Beatrice Darimont, Wei Zhou, et al.
Pageof 4

Showing results (21-30 of 31) with videos related to

Sort By:
Pageof 4
Cell|July 30, 2019
Therapeutic Ligands Antagonize Estrogen Receptor Function by Impairing Its MobilityJane Guan, Wei Zhou, Marc Hafner, et al.
Bioorganic & Medicinal Chemistry Letters|August 23, 2021
Discovery of GNE-502 as an orally bioavailable and potent degrader for estrogen receptor positive breast cancerJason R Zbieg, Jun Liang, Jun Li, et al.
Chemistry (Weinheim an Der Bergstrasse, Germany)|March 2, 2018
Conjugation of Indoles to Antibodies through a Novel Self-Immolating LinkerPeter S Dragovich, Robert A Blake, Chunjiao Chen, et al.
Chemmedchem|November 2, 2019
Antibody Conjugation of a Chimeric BET Degrader Enables in vivo ActivityThomas H Pillow, Pragya Adhikari, Robert A Blake, et al.
Journal of Medicinal Chemistry|February 17, 2021
Antibody-Mediated Delivery of Chimeric BRD4 Degraders. Part 1: Exploration of Antibody Linker, Payload Loading, and Payload Molecular PropertiesPeter S Dragovich, Thomas H Pillow, Robert A Blake, et al.
Journal of Medicinal Chemistry|February 17, 2021
Antibody-Mediated Delivery of Chimeric BRD4 Degraders. Part 2: Improvement of In Vitro Antiproliferation Activity and In Vivo Antitumor EfficacyPeter S Dragovich, Thomas H Pillow, Robert A Blake, et al.
Bioorganic & Medicinal Chemistry Letters|January 7, 2020
Antibody-mediated delivery of chimeric protein degraders which target estrogen receptor alpha (ERα)Peter S Dragovich, Pragya Adhikari, Robert A Blake, et al.
Nature|October 19, 2017
USP7 small-molecule inhibitors interfere with ubiquitin bindingLorna Kategaya, Paola Di Lello, Lionel Rougé, et al.
Elife|July 14, 2016
The selective estrogen receptor downregulator GDC-0810 is efficacious in diverse models of ER+ breast cancerJames D Joseph, Beatrice Darimont, Wei Zhou, et al.
Elife|January 8, 2019
Correction: The selective estrogen receptor downregulator GDC-0810 is efficacious in diverse models of ER+ breast cancerJames D Joseph, Beatrice Darimont, Wei Zhou, et al.
Pageof 4